Shanghai Kehua Bio-engineering Co (SZSE:002022) EV-to-EBIT : -9.68 (As of May. 26, 2024)

Shanghai Kehua Bio-engineering Co EV-to-EBIT Chart

Shanghai Kehua Bio-engineering Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					17.97	5.52	4.25	2.28	-39.65

Shanghai Kehua Bio-engineering Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															2.59	2.35	-47.77	-39.65	-14.67

Competitive Comparison of Shanghai Kehua Bio-engineering Co's EV-to-EBIT

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Kehua Bio-engineering Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's EV-to-EBIT falls into.

Shanghai Kehua Bio-engineering Co EV-to-EBIT Calculation

Shanghai Kehua Bio-engineering Co's EV-to-EBIT for today is calculated as:

Shanghai Kehua Bio-engineering Co's current Enterprise Value is ¥2,720 Mil.
Shanghai Kehua Bio-engineering Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-281 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Kehua Bio-engineering Co  (SZSE:002022) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Shanghai Kehua Bio-engineering Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Shanghai Kehua Bio-engineering Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥4,124 Mil.
Shanghai Kehua Bio-engineering Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-281 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Kehua Bio-engineering Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description